Related Experiment Video
Updated: Apr 5, 2026

Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris
Published on: February 25, 2010
Expression, purification and initial characterization of human meprin β from Pichia pastoris
D Schlenzig1, M Wermann1, D Ramsbeck1
1Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation (IZI-MWT), Weinbergweg 22, 06120 Halle/Saale, Germany.
Abstract:
Human meprin β (h-meprin β), a single-zinc metalloendoprotease of the astacin family, is potentially involved in disorders such as fibrosis and Alzheimer's disease. Here, we describe the expression of the enzyme in the yeast Pichia pastoris. The N-terminal signal sequence was replaced by the α-leader of Saccharomyces, enabling efficient secretion of the mature enzyme, harboring either an N-terminal or C-terminal His-tag. The purification by affinity and hydrophobic interaction chromatography resulted in isolation of 58.4 mg/l of homogenous human pro-meprin β from fermentation broth. The activated enzyme isolated from yeast (yh-meprin β) displayed virtually identical enzymatic activity as h-meprin from a mammalian cell line. Furthermore, the yh-meprin β was N-glycosylated and secreted as a dimer with a molecular mass of 148 kDa. Endoglycosidase H treatment generated a protein with a molecular mass of 133 kDa, but essentially unchanged kinetic parameters. Thus, our data suggest that human meprin β expressed in P. pastoris displays virtually identical parameters as meprin from other sources. The high yield of protein expression, the ease of purification and the deglycosylation in its native state appear to favor further studies aiming at inhibitor screening and structure-based inhibitor refinement.
Insights
Researchers expressed human meprin β (h-meprin β) in yeast, achieving high yields of a purified enzyme with activity identical to mammalian sources. This Pichia pastoris expression system facilitates further studies for drug development.
Area of Science:
- Biochemistry
- Molecular Biology
- Biotechnology
Background:
- Human meprin β (h-meprin β) is a metalloendoprotease implicated in diseases like fibrosis and Alzheimer's.
- Efficient production of active h-meprin β is crucial for therapeutic and structural studies.
Purpose of the Study:
- To establish a Pichia pastoris expression system for producing active human meprin β.
- To characterize the biochemical properties of yeast-expressed h-meprin β.
Main Methods:
- Engineered h-meprin β with a modified signal sequence for secretion in Pichia pastoris.
- Purified the enzyme using affinity and hydrophobic interaction chromatography.
- Assessed enzymatic activity and characterized glycosylation and oligomeric state.
Main Results:
- Isolated 58.4 mg/l of homogenous human pro-meprin β.
- Yeast-derived h-meprin β (yh-meprin β) exhibited enzymatic activity comparable to mammalian sources.
- yh-meprin β was secreted as an N-glycosylated dimer (148 kDa), with deglycosylation yielding a 133 kDa protein with unchanged kinetics.
Conclusions:
- Pichia pastoris is a suitable host for high-yield expression of active human meprin β.
- The characterized yh-meprin β demonstrates properties similar to native h-meprin β, supporting its use in inhibitor screening and drug refinement.

